These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Allan L; Hays H; Jensen NH; de Waroux BL; Bolt M; Donald R; Kalso E BMJ; 2001 May; 322(7295):1154-8. PubMed ID: 11348910 [TBL] [Abstract][Full Text] [Related]
23. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study). Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716 [TBL] [Abstract][Full Text] [Related]
24. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Wong JO; Chiu GL; Tsao CJ; Chang CL Acta Anaesthesiol Sin; 1997 Mar; 35(1):25-32. PubMed ID: 9212478 [TBL] [Abstract][Full Text] [Related]
25. [Parenteral opioids in end-of-life care in cancer patients]. Hattori S; Kimura N; Takatani J; Noguchi T Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626 [TBL] [Abstract][Full Text] [Related]
26. Opioids for acute pancreatitis pain. Basurto Ona X; Rigau Comas D; Urrútia G Cochrane Database Syst Rev; 2013 Jul; (7):CD009179. PubMed ID: 23888429 [TBL] [Abstract][Full Text] [Related]
27. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study. Sittl R; Likar R; Nautrup BP Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486 [TBL] [Abstract][Full Text] [Related]
28. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. Ahmedzai S; Brooks D J Pain Symptom Manage; 1997 May; 13(5):254-61. PubMed ID: 9185430 [TBL] [Abstract][Full Text] [Related]
29. Opioid Rotation in Cancer Pain Treatment. Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006 [TBL] [Abstract][Full Text] [Related]
30. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. Payne R; Mathias SD; Pasta DJ; Wanke LA; Williams R; Mahmoud R J Clin Oncol; 1998 Apr; 16(4):1588-93. PubMed ID: 9552070 [TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521 [TBL] [Abstract][Full Text] [Related]
32. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain. Mitra F; Chowdhury S; Shelley M; Williams G Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402 [TBL] [Abstract][Full Text] [Related]
33. High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain. Amato F; Ceniti S; Mameli S; Pisanu GM; Vellucci R; Palmieri V; Consoletti L; Magaldi D; Notaro P; Marcassa C Support Care Cancer; 2017 Oct; 25(10):3051-3058. PubMed ID: 28470370 [TBL] [Abstract][Full Text] [Related]
34. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD). van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574 [TBL] [Abstract][Full Text] [Related]
35. Pediatric palliative care: use of opioids for the management of pain. Zernikow B; Michel E; Craig F; Anderson BJ Paediatr Drugs; 2009; 11(2):129-51. PubMed ID: 19301934 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial. Sima L; Fang WX; Wu XM; Li F J Clin Pharm Ther; 2012 Feb; 37(1):27-31. PubMed ID: 21208247 [TBL] [Abstract][Full Text] [Related]
37. Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients. Weschules DJ; Bain KT; Reifsnyder J; McMath JA; Kupperman DE; Gallagher RM; Hauck WW; Knowlton CH Pain Med; 2006; 7(4):320-9. PubMed ID: 16898943 [TBL] [Abstract][Full Text] [Related]
38. New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents. Pimentel CB; Gurwitz JH; Tjia J; Hume AL; Lapane KL J Am Geriatr Soc; 2016 Sep; 64(9):1772-8. PubMed ID: 27487158 [TBL] [Abstract][Full Text] [Related]
39. In contrast to morphine, buprenorphine enhances macrophage-induced humoral immunity and, as oxycodone, slightly suppresses the effector phase of cell-mediated immune response in mice. Filipczak-Bryniarska I; Nazimek K; Nowak B; Kozlowski M; Wąsik M; Bryniarski K Int Immunopharmacol; 2018 Jan; 54():344-353. PubMed ID: 29197801 [TBL] [Abstract][Full Text] [Related]
40. Opioid-induced constipation in chronic pain: Experience with 180 patients. Velázquez Rivera I; Velázquez Clavarana L; García Velasco P; Melero Ramos C J Opioid Manag; 2019; 15(1):69-76. PubMed ID: 30855724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]